EUVIMEDEUVIMED entdecken
Crossref

Calcineurin inhibitor‐related hyperkalemia is caused by hyporeninemic hypoaldosteronism and fludrocortisone is an effective treatment: Report of a case series and review of the literature

Yagmur Unsal iD, Demet Baltu iD, Bora Gulhan iD, Fatma Visal Okur, Fatih Ozaltın iD, Ali Düzova iD, Rezan Topaloğlu iD, Zeynep Alev Ozon iD, Elmas Nazlı Gonç iD

Pediatric Transplantation · 2024-06 · 28 (4)

DOI: 10.1111/petr.14778 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Transplantation, online erschienen am 20.05.2024. Verfasst von Yagmur Unsal und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Endocrinology, Department of Pediatrics, Hacettepe University Faculty of Medicine, Ankara, Turkey. Hauptthemen laut MEDLINE: Calcineurin Inhibitors, Fludrocortisone, Hematopoietic Stem Cell Transplantation, Hyperkalemia. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Calcineurin inhibitors (CNIs) are widely used in transplantation. Although CNI‐related hyperkalemia is common (10%–60.6%), the underlying pathogenetic mechanism is not well‐elucidated and may lead to dose adjustment or treatment withdrawal.

Objective

The aim of this study is to describe CNI‐related hyperkalemia due to hyporeninemic hypoaldosteronism in pediatric transplant recipients who were successfully treated with fludrocortisone.

Method

In a total of 55 hematopoietic stem cell (HSCT) and 35 kidney transplant recipients followed according to institutional immunosuppression protocols, recipients diagnosed with CNI‐related hyperkalemia were reviewed. Recipients who were receiving intravenous fluid, potassium, or were diagnosed with hemolysis, acute graft rejection, or had an eGFR < 30 mL/min/1.73m 2 , were excluded. A detailed analysis of clinical history as well as biochemical studies was carried out to reveal possible pathophysiology.

Results

Three pediatric transplant recipients (one HSCT, two kidney transplantation) with findings of hyperkalemia, hyponatremia, and a mild elevation in blood urea nitrogen while on CNIs were recruited. Urinary potassium excretion was diminished while sodium excretion was increased. Plasma aldosterone levels were low, and renin was not increased in response. Primary adrenal insufficiency was ruled out, and hyporeninemic hypoaldosteronism was diagnosed. CNI‐related hyperkalemia was detected earlier in case 1, who had HSCT (22 days), than in the second and third cases, who had kidney transplantation (24 and 30 months post‐transplantation, respectively). The discrepancy was hypothesized to be explained by higher overall CNI dose due to higher serum target CNI used in HSCT than kidney transplantation. Electrolyte imbalance was reversed upon administration of physiologic dose fludrocortisone (0.05 mg, daily), while fludrocortisone was ceased after CNI withdrawal in case 1, which is additional evidence for the etiological association of CNIs and hyporeninemic hypoaldosteronism.

Conclusion

Our three cases strengthen the premise that CNI‐related hyperkalemia may be due to hyporeninemic hypoaldosteronism, and the timing and severity may be related to CNI dose. Fludrocortisone is a safe and effective treatment in CNI‐related hyperkalemia, providing maintenance of CNIs, which are one of the essential therapeutic agents for pediatric transplantation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Calcineurin InhibitorsFludrocortisoneHematopoietic Stem Cell TransplantationHyperkalemiaHypoaldosteronismKidney TransplantationChild, PreschoolFemaleHumansMaleTreatment OutcomeInfant

Stichwörter der Autor:innen

aldosteronecalcineurin inhibitorcyclosporinehyperkalemiahyporeninemic hypoaldosteronismpediatricrenintacrolimustransplantation

Substanzen

Calcineurin InhibitorsFludrocortisone

Autor:innen und Institutionen

  • Division of Pediatric Endocrinology, Department of Pediatrics, Hacettepe University Faculty of Medicine, Ankara, Turkey.
  • Division of Pediatric Nephrology, Department of Pediatrics, Hacettepe University Faculty of Medicine, Ankara, Turkey.
  • Division of Pediatric Hematology, Department of Pediatrics, Hacettepe University Faculty of Medicine, Ankara, Turkey.

ORCID-Profile: Yagmur Unsal, Demet Baltu, Bora Gulhan, Fatih Ozaltın, Ali Düzova, Rezan Topaloğlu, Zeynep Alev Ozon, Elmas Nazlı Gonç

Zitieren

APA

Unsal, Y., Baltu, D., Gulhan, B., Okur, F. V., Ozaltın, F., Düzova, A., Topaloğlu, R., Ozon, Z. A., & Gonç, E. N. (2024). Calcineurin inhibitor‐related hyperkalemia is caused by hyporeninemic hypoaldosteronism and fludrocortisone is an effective treatment: Report of a case series and review of the literature. Pediatric Transplantation, 28(4). https://doi.org/10.1111/petr.14778

Vancouver

Unsal Y, Baltu D, Gulhan B, Okur FV, Ozaltın F, Düzova A, et al. Calcineurin inhibitor‐related hyperkalemia is caused by hyporeninemic hypoaldosteronism and fludrocortisone is an effective treatment: Report of a case series and review of the literature. Pediatric Transplantation. 2024;28(4). doi:10.1111/petr.14778

BibTeX
@article{Unsal2024,
  author = {Unsal, Yagmur and Baltu, Demet and Gulhan, Bora and Okur, Fatma Visal and Ozaltın, Fatih and Düzova, Ali and Topaloğlu, Rezan and Ozon, Zeynep Alev and Gonç, Elmas Nazlı},
  title = {Calcineurin inhibitor‐related hyperkalemia is caused by hyporeninemic hypoaldosteronism and fludrocortisone is an effective treatment: Report of a case series and review of the literature},
  journal = {Pediatric Transplantation},
  year = {2024},
  volume = {28},
  number = {4},
  doi = {10.1111/petr.14778}
}
Kostenlos starten →